Hormone releasing intrauterine system should be used more widely in primary care for menorrhagia, study concludes

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f100 (Published 9 January 2013)
Cite this as: BMJ 2013;346:f100

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Zosia Kmietowicz
  1. 1BMJ

Women with menorrhagia reported more improvement in bleeding and quality of life with the levonorgestrel releasing intrauterine system than with other treatments available in primary care, a two year study in England has found.1

Women fitted with the levonorgestrel releasing intrauterine system (also known as LNG-IUS or Mirena) were also more likely to stick with treatment, found the study, called the Effectiveness and Cost-Effectiveness of Levonorgestrel-Containing Intrauterine System in Primary Care against Standard Treatment for Menorrhagia (ECLIPSE) study.

Researchers from the Universities of Birmingham and Nottingham randomised 571 …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL